NO176020C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-substituert-tetrahydrobenz(cd)indoler og mellomprodukter - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-substituert-tetrahydrobenz(cd)indoler og mellomprodukter

Info

Publication number
NO176020C
NO176020C NO913159A NO913159A NO176020C NO 176020 C NO176020 C NO 176020C NO 913159 A NO913159 A NO 913159A NO 913159 A NO913159 A NO 913159A NO 176020 C NO176020 C NO 176020C
Authority
NO
Norway
Prior art keywords
tetrahydrobenz
indoles
substituted
intermediates
therapeutically active
Prior art date
Application number
NO913159A
Other languages
English (en)
Norwegian (no)
Other versions
NO176020B (no
NO913159L (no
NO913159D0 (no
Inventor
Michael Edward Flaugh
Michael John Martinelli
John Mehnert Schaus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO913159D0 publication Critical patent/NO913159D0/no
Publication of NO913159L publication Critical patent/NO913159L/no
Publication of NO176020B publication Critical patent/NO176020B/no
Publication of NO176020C publication Critical patent/NO176020C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO913159A 1990-08-15 1991-08-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-substituert-tetrahydrobenz(cd)indoler og mellomprodukter NO176020C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56799090A 1990-08-15 1990-08-15
US07/725,175 US5229409A (en) 1990-08-15 1991-07-03 6-substituted-tetrahydrobenz[cd]indoles

Publications (4)

Publication Number Publication Date
NO913159D0 NO913159D0 (no) 1991-08-13
NO913159L NO913159L (no) 1992-02-17
NO176020B NO176020B (no) 1994-10-10
NO176020C true NO176020C (no) 1995-01-18

Family

ID=27074632

Family Applications (1)

Application Number Title Priority Date Filing Date
NO913159A NO176020C (no) 1990-08-15 1991-08-13 Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-substituert-tetrahydrobenz(cd)indoler og mellomprodukter

Country Status (25)

Country Link
US (1) US5229409A (cs)
EP (1) EP0471576B1 (cs)
JP (1) JP3034085B2 (cs)
KR (1) KR100221159B1 (cs)
CN (1) CN1031999C (cs)
AT (1) ATE234285T1 (cs)
AU (1) AU648575B2 (cs)
BR (1) BR9103481A (cs)
CA (1) CA2049212C (cs)
CZ (1) CZ280605B6 (cs)
DE (1) DE69133212T2 (cs)
DK (1) DK0471576T3 (cs)
ES (1) ES2194007T3 (cs)
FI (1) FI102677B (cs)
HU (1) HU220757B1 (cs)
IE (1) IE912878A1 (cs)
IL (1) IL99148A (cs)
MX (1) MX9100646A (cs)
MY (1) MY106764A (cs)
NO (1) NO176020C (cs)
NZ (1) NZ239333A (cs)
PT (1) PT98640B (cs)
RU (1) RU2073672C1 (cs)
TW (1) TW197422B (cs)
YU (1) YU48058B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
TW219933B (cs) * 1990-02-26 1994-02-01 Lilly Co Eli
US5340838A (en) * 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
US5089517A (en) * 1990-08-03 1992-02-18 The Board Of Trustees Of The Leland Stanford Junior University Neuroprotection by indolactam v and derivatives thereof
US5229410A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
NZ314570A (en) * 1993-06-10 2000-11-24 Lilly Co Eli Treatment of emesis using tetrahydrobenz[cd]indole-6-carboxamides
US5385928A (en) * 1994-05-18 1995-01-31 Eli Lilly And Company Tetrahydrobenz [CD] indazoles, compositions and use

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE517732C (de) * 1927-10-27 1931-02-09 Then Rudolf Faerbekufe mit einem drehbaren, trommelartigen Rahmen fuer die auf aus-wechselbaren Faerbestoecken aufgehaengten Waren, insbesondere Struempfe
US3194811A (en) * 1963-09-05 1965-07-13 Merck & Co Inc Aroyl-benzindolyl acids
BE755270A (fr) * 1969-08-27 1971-02-25 Sandoz Sa Nouveaux derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
BE757879A (fr) * 1969-10-24 1971-04-22 Sandoz Sa Derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
FI206974A7 (cs) * 1973-07-16 1975-01-17 Sandoz Ag
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
US4282240A (en) * 1979-11-23 1981-08-04 Merck & Co., Inc. Amino substituted tetrahydrobenzindoles
FR2510111A1 (fr) * 1981-07-24 1983-01-28 Roussel Uclaf Nouveaux derives du piperidin-3-yl indole, leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
FR2522658A1 (fr) * 1982-03-05 1983-09-09 Roussel Uclaf Application a titre de medicaments de derives du trans 4-amino benz (c,d) indol-5-ol ainsi que de leurs sels, compositions les renfermant, nouveaux derives et leur procede de preparation
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
US4983622A (en) * 1984-02-06 1991-01-08 Eli Lilly And Company 6-substituted-4-dialkylaminotetrahydrobenz(c,d)indoles
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
DE3525564A1 (de) * 1985-07-15 1987-02-05 Schering Ag Tricyclische verbindungen mit indolstruktur, verfahren zu ihrer herstellung und deren verwendung als arzneimittel
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
JPH07103105B2 (ja) * 1989-05-12 1995-11-08 杏林製薬株式会社 インドール誘導体及びその製造方法
US5039820A (en) * 1990-02-26 1991-08-13 Eli Lilly And Company 4-amino-6-iodo-hexahydrobenz(cd)indoles
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion

Also Published As

Publication number Publication date
JPH04230663A (ja) 1992-08-19
FI913835A0 (fi) 1991-08-13
TW197422B (cs) 1993-01-01
NZ239333A (en) 1993-05-26
PT98640B (pt) 1999-01-29
JP3034085B2 (ja) 2000-04-17
NO176020B (no) 1994-10-10
ES2194007T3 (es) 2003-11-16
DE69133212T2 (de) 2003-11-20
CA2049212A1 (en) 1992-02-16
IE912878A1 (en) 1992-02-26
AU8240691A (en) 1992-02-27
CS249491A3 (en) 1992-03-18
HUT59094A (en) 1992-04-28
HU220757B1 (hu) 2002-05-28
DE69133212D1 (de) 2003-04-17
DK0471576T3 (da) 2003-12-01
ATE234285T1 (de) 2003-03-15
EP0471576A1 (en) 1992-02-19
MY106764A (en) 1995-07-31
AU648575B2 (en) 1994-04-28
FI102677B1 (fi) 1999-01-29
MX9100646A (es) 1992-04-01
KR100221159B1 (ko) 1999-09-15
EP0471576B1 (en) 2003-03-12
PT98640A (pt) 1992-06-30
NO913159L (no) 1992-02-17
YU48058B (sh) 1996-10-18
NO913159D0 (no) 1991-08-13
US5229409A (en) 1993-07-20
HU912706D0 (en) 1992-01-28
CA2049212C (en) 2003-04-08
CZ280605B6 (cs) 1996-03-13
IL99148A (en) 1995-12-08
KR920004347A (ko) 1992-03-27
FI102677B (fi) 1999-01-29
CN1031999C (zh) 1996-06-12
BR9103481A (pt) 1992-05-12
CN1058961A (zh) 1992-02-26
YU140491A (sh) 1994-01-20
RU2073672C1 (ru) 1997-02-20
FI913835L (fi) 1992-02-16

Similar Documents

Publication Publication Date Title
HU911771D0 (en) Process for producing substituted and heterocyclic phthalides
NO990542D0 (no) K-252a-derivater og anvendelse av K-252a-derivater
NO884591D0 (no) Apparat for regulering av intraokulaert trykk.
FI102069B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmistamiseksi
FI910895A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 4-(di-n-propyyli)amino-6-aminokarbonyyli-1,3,4,5-tetrahydrobentso/c,d/indolihippuraatin valmistam iseksi
FI930150L (fi) Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi
BG94868A (bg) Мутант на бактерията сlоsтrifiuм нisтоlyтiсuм, метод за получаването му и използуването му за производство на свободна от клострипаин колагеназа
FI925260L (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-amino-substituoitujen oktahydro-1,7,8-indolitsiinitriolijohdannaisten valmistamiseksi
FI102677B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-asyylisubstituoitujen 4-aminotetrahydrobentso[cd]indolien valmistamiseksi
DK0444853T3 (da) Hexahydrobenz(cd)indoler
HU913180D0 (en) Process for the production of optically active amines
NO990450D0 (no) Behandling av sinnslidelser
FI102173B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten heksahydrobents[CD]indolien valmistamiseksi
FI953361L (fi) Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi
NO903338D0 (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
PH23992A (en) Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same
FI910448A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3b/indolijohdannaisten valmistamiseksi
FI911282L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3,4-dihydroksi-2,5-dihydrofuranonien valmistamiseksi
NO893207L (no) Avsoekningsanordning for kvalitetskontroll av gjenstander med ultralyd.
FI885001L (fi) Foerfarande foer produktion av fumarsyra.
ZA91358B (en) Process for the production of 3-(1-amino-1,3-dicarboxy-3-hydroxy-but-4-yl)indole